Synopsis
This report presents the findings from a survey of 102 pharmaceutical regarding their Information & Communications Technology (ICT) investment priorities. The survey investigates the core technologies which pharmaceutical companies are investing in, including the likes of enterprise applications, security, mobility, communications & collaboration, and Cloud Computing.
Scope
Recognize pharmaceutical companies’ strategic objectives with regards to their ICT investments.
Identify pharmaceutical companies’ investment priorities based on their budget allocations across core technology categories such as enterprise applications, security, mobility, communications & collaboration, and Cloud Computing, etc.
Learn about the drivers that are influencing pharmaceutical companies’ investments in each technology category.
Establish how pharmaceutical companies’ IT budgets are currently allocated across various segments within a technology category.
Gain insight into how pharmaceutical companies’ plan to change their ICT budget allocations across various segments within a technology category.
Summary
Why was the report written?
In order to provide deeper insights into pharmaceutical companies’ ICT investment priorities and strategic objectives.
What is the current market landscape and what is changing?
Kable Market Research’s survey finds that apart from investing in core technologies (such as security, enterprise applications, and IT systems management), many pharmaceutical companies are looking to adopt green IT and virtualization, cloud computing, mobility, and business intelligence solutions.
What are the key drivers behind recent market changes?
Demand for such advanced technologies are increasing amongst pharmaceutical companies as these solutions will help them to reduce their costs, enhance operational efficiencies, achieve sustainability, and improve customer experience.
What makes this report unique and essential to read?
Kable Market Research Market Research has invested significant resources in order to interview CIOs and IT managers about their IT investment priorities. Very few IT analyst houses will have interviewed 100+ ICT decision makers in pharmaceutical industry in H2 2012.
Reasons To Buy
The demand for security solutions is set to continue, with 87% of survey respondents planning investments in this area in the next two years, owing to the increasing adoption of enterprise mobility and rising data security threats in pharmaceutical companies.
Companies in the pharmaceutical sector are keen to deploy a cost effective supply chain solution in order to streamline their operations.
In order to curb the impact of competition and regulatory changes pharmaceuticals companies are looking to adopt various predictive analytics and modelling tools in order to make smarter business decisions by understanding the latest market trends and customer preferences.
Managing and monitoring the ever increasing volumes of information across a global organisation is a complex task, which is driving the adoption of various enterprise content management (ECM) solutions.
The increasing complexity of enterprise ICT infrastructure is consequently driving the demand for IT systems management to manage ICT assets effectively and keep them running efficiently, while at the same time removing any redundancies and wastage of resources.
Table of Contents
1 Enterprise ICT investment trends
1.1 Introduction
1.2 Survey demographics
1.3 ICT budget changes
1.4 Strategic objectives
1.5 Core technology investment priorities
2 Detailed ICT investment priorities
2.1 Introduction
2.2 Enterprise applications
2.3 Business intelligence
2.4 Security
2.5 Content management
2.6 Mobility
2.7 IT systems management
2.8 Communications & collaboration
2.9 Green IT & virtualization
2.10 Cloud computing solutions
3 Summary
3.1 Intense competition among pharmaceutical companies is driving the adoption of advanced technologies such as cloud and tablet computing
4 Appendix
4.1 Definitions
4.2 Further reading
4.3 Contact the authors
List Of Tables
Table 1: Pharmaceuticals – enterprise ICT survey geographic breakdown
Table 2: Pharmaceuticals – enterprise ICT survey breakdown by size band (number of employees)
Table 3: Recent and expected ICT budget changes among pharmaceutical companies
Table 4: Current strategic objectives of pharmaceutical companies
Table 5: Current and future investment priorities of pharmaceutical companies across core technologies
Table 6: Enterprise applications – pharmaceutical companies’ current and future investment priorities
Table 7: Business intelligence – pharmaceutical companies’ current and future investment priorities
Table 8: Security – pharmaceutical companies’ current and future investment priorities
Table 9: Content management – pharmaceutical companies’ current and future investment priorities
Table 10: Mobility – pharmaceutical companies’ current and future investment priorities
Table 11: IT systems management – pharmaceutical companies’ current and future investment priorities
Table 12: Communications & collaboration – pharmaceutical companies’ current and future investment priorities
Table 13: Green IT & virtualization – pharmaceutical companies’ current and future investment priorities
Table 14: Cloud computing solutions – pharmaceutical companies’ current and future investment priorities
List Of Figures
Figure 1: Pharmaceuticals – enterprise ICT survey geographic breakdown
Figure 2: Pharmaceuticals – enterprise ICT survey breakdown by size band (number of employees)
Figure 3: Recent and expected ICT budget changes among pharmaceutical companies
Figure 4: Current strategic objectives of pharmaceutical companies
Figure 5: Current and future investment priorities of pharmaceutical companies across core technologies.
Figure 6: Enterprise applications – pharmaceutical companies’ current and future investment priorities
Figure 7: Business intelligence – pharmaceutical companies’ current and future investment priorities
Figure 8: Security – pharmaceutical companies’ current and future investment priorities
Figure 9: Content management – pharmaceutical companies’ current and future investment priorities
Figure 10: Mobility – pharmaceutical companies’ current and future investment priorities
Figure 11: IT systems management – pharmaceutical companies’ current and future investment priorities.
Figure 12: Communications & collaboration – pharmaceutical companies’ current and future investment priorities
Figure 13: Green IT & virtualization – pharmaceutical companies’ current and future investment priorities.
Figure 14: Cloud computing solutions – pharmaceutical companies’ current and future investment priorities
